FDA
Bethanechol Chloride
The FDA lists this product in 60 strengths and forms.
Indications
Bethanechol chloride tablets are indicated for the treatment of acute postoperative and postpartum nonobstructive (functional) urinary retention and for neurogenic atony of the urinary bladder with retention.
Contraindications
Hypersensitivity to bethanechol chloride tablets, hyperthyroidism, peptic ulcer, latent or active bronchial asthma, pronounced bradycardia or hypotension, vasomotor instability, coronary artery disease, epilepsy and parkinsonism. Bethanechol chloride should not be employed when the strength or integrity of the gastrointestinal or bladder wall is in question, or in the presence of mechanical obstruction; when increased muscular activity of the gastrointestinal tract or urinary bladder might prove harmful, as following recent urinary bladder surgery, gastrointestinal resection and anastomosis, or when there is possible gastrointestinal obstruction; in bladder neck obstruction, spastic gastrointestinal disturbances, acute inflammatory lesions of the gastrointestinal tract, or peritonitis; or in marked vagotonia.
Interactions
Drug Interactions Special care is required if this drug is given to patients receiving ganglion blocking compounds because a critical fall in blood pressure may occur. Usually, severe abdominal symptoms appear before there is such a fall in the blood pressure.
Pregnancy and breastfeeding
Pregnancy Teratogenic Effects Animal reproduction studies have not been conducted with bethanechol chloride. It is also not known whether bethanechol chloride can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Bethanechol chloride should be given to a pregnant woman only if clearly needed.
Adverse reactions
Adverse reactions are rare following oral administration of bethanechol chloride, but are more common following subcutaneous injection. Adverse reactions are more likely to occur when dosage is increased. The following adverse reactions have been observed: Body as a Whole : malaise; Digestive : abdominal cramps or discomfort, colicky pain, nausea and belching, diarrhea, borborygmi, salivation; Renal : urinary urgency; Nervous System : headache; Cardiovascular : a fall in blood pressure with reflex tachycardia, vasomotor response; Skin : flushing producing a feeling of warmth, sensation of heat about the face, sweating; Respiratory : bronchial constriction, asthmatic attacks; Special Senses : lacrimation, miosis.
At a glance
- Brand name
- Bethanechol Chloride
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Upsher Smith Labs
- Status
- Prescription
- FDA approval
- 1 Jun 2005
- Application
- ANDA040633-001



